JP3338913B2 - テトラゾール誘導体 - Google Patents

テトラゾール誘導体

Info

Publication number
JP3338913B2
JP3338913B2 JP13875694A JP13875694A JP3338913B2 JP 3338913 B2 JP3338913 B2 JP 3338913B2 JP 13875694 A JP13875694 A JP 13875694A JP 13875694 A JP13875694 A JP 13875694A JP 3338913 B2 JP3338913 B2 JP 3338913B2
Authority
JP
Japan
Prior art keywords
compound
atom
tetrazol
piperidine
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP13875694A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0770112A (ja
Inventor
雅俊 林
正也 加藤
祐輔 境
和彦 三井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP13875694A priority Critical patent/JP3338913B2/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to AU69830/94A priority patent/AU673754B2/en
Priority to CA002165792A priority patent/CA2165792A1/en
Priority to PCT/JP1994/001010 priority patent/WO1995001350A1/en
Priority to EP94918560A priority patent/EP0706522A1/en
Priority to CN 94192626 priority patent/CN1126471A/zh
Priority to KR1019950705952A priority patent/KR960703405A/ko
Priority to TW083105824A priority patent/TW281677B/zh
Priority to IL11014494A priority patent/IL110144A0/xx
Publication of JPH0770112A publication Critical patent/JPH0770112A/ja
Application granted granted Critical
Publication of JP3338913B2 publication Critical patent/JP3338913B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP13875694A 1993-06-29 1994-06-21 テトラゾール誘導体 Expired - Fee Related JP3338913B2 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP13875694A JP3338913B2 (ja) 1993-06-29 1994-06-21 テトラゾール誘導体
CA002165792A CA2165792A1 (en) 1993-06-29 1994-06-23 Tetrazole derivatives
PCT/JP1994/001010 WO1995001350A1 (en) 1993-06-29 1994-06-23 Tetrazole derivatives having antihistaminic and antiallergic activity
EP94918560A EP0706522A1 (en) 1993-06-29 1994-06-23 Tetrazole derivatives having antihistaminic and antiallergic activity
AU69830/94A AU673754B2 (en) 1993-06-29 1994-06-23 Tetrazole derivatives having antihistaminic and antiallergic activity
CN 94192626 CN1126471A (zh) 1993-06-29 1994-06-23 四唑衍生物
KR1019950705952A KR960703405A (ko) 1993-06-29 1994-06-23 항-히스타민 및 항-알레르기 활성을 갖는 테트라졸 유도체(tetrazole derivatives having antihistaminic and antiallergic activity)
TW083105824A TW281677B (enExample) 1993-06-29 1994-06-27
IL11014494A IL110144A0 (en) 1993-06-29 1994-06-28 Tetrazole derivatives

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP15874193 1993-06-29
JP5-158741 1993-06-29
JP15874593 1993-06-29
JP5-158745 1993-06-29
JP13875694A JP3338913B2 (ja) 1993-06-29 1994-06-21 テトラゾール誘導体

Publications (2)

Publication Number Publication Date
JPH0770112A JPH0770112A (ja) 1995-03-14
JP3338913B2 true JP3338913B2 (ja) 2002-10-28

Family

ID=27317735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13875694A Expired - Fee Related JP3338913B2 (ja) 1993-06-29 1994-06-21 テトラゾール誘導体

Country Status (8)

Country Link
EP (1) EP0706522A1 (enExample)
JP (1) JP3338913B2 (enExample)
KR (1) KR960703405A (enExample)
AU (1) AU673754B2 (enExample)
CA (1) CA2165792A1 (enExample)
IL (1) IL110144A0 (enExample)
TW (1) TW281677B (enExample)
WO (1) WO1995001350A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
EP0916668A4 (en) * 1996-07-29 2000-08-16 Banyu Pharma Co Ltd CHEMOKIN RECEPTOR ANTAGONISTS
ES2172436B1 (es) * 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
WO2003032912A2 (en) 2001-10-16 2003-04-24 Hypnion, Inc. Treatment of cns disorders using cns target modulators
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7189757B2 (en) 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
AU2003296373A1 (en) * 2002-12-18 2004-07-29 Bayer Cropscience Ag N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
US7326721B2 (en) 2003-12-10 2008-02-05 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7411069B2 (en) 2003-12-10 2008-08-12 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7482460B2 (en) 2003-12-10 2009-01-27 Hypnion, Inc. Doxepin analogs and methods of use thereof
WO2005102335A2 (en) * 2004-04-23 2005-11-03 Hypnion, Inc. Methods of treating sleep disorders
US20080214570A1 (en) * 2005-08-08 2008-09-04 Astrazeneca Ab Therapeutic Agents
WO2010013805A1 (ja) * 2008-08-01 2010-02-04 日本臓器製薬株式会社 アミノプロピリデン誘導体
JP7040802B2 (ja) * 2017-06-30 2022-03-23 株式会社ニコン 光学装置を製造する方法及び対応するシステム
JP6991315B2 (ja) 2018-04-19 2022-01-12 国立大学法人東京農工大学 サルコペニアの予防剤及び治療剤
CN113880808B (zh) * 2020-07-03 2024-12-31 合肥医工医药股份有限公司 一类三唑类化合物、制备方法及其医药用途
EP4691466A1 (en) 2023-07-25 2026-02-11 The Eye Hospital of Wenzhou Medical University Use of ptgds inhibitor in preparation of drug for treating cataracts
CN117599052A (zh) * 2023-07-25 2024-02-27 温州医科大学附属眼视光医院 Ptgds的抑制剂在制备治疗白内障药物上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
JPH03246287A (ja) * 1990-02-22 1991-11-01 Hokuriku Seiyaku Co Ltd ピペラジン誘導体
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
CA2165792A1 (en) 1995-01-12
AU673754B2 (en) 1996-11-21
JPH0770112A (ja) 1995-03-14
KR960703405A (ko) 1996-08-17
AU6983094A (en) 1995-01-24
IL110144A0 (en) 1994-10-07
TW281677B (enExample) 1996-07-21
EP0706522A1 (en) 1996-04-17
WO1995001350A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
JP3338913B2 (ja) テトラゾール誘導体
JP3218037B2 (ja) 喘息および呼吸器官の炎症の治療に有用なヘテロサイクリックアミン類
JP4529685B2 (ja) ジアミノピリミジンカルボキサミド誘導体
DE69330823T2 (de) Thiacyclische piperidinylderivate
US4680296A (en) Piperidine derivatives and pharmaceutical compositions containing them
WO2000064884A1 (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
JP2008538557A (ja) 神経治療アゾール化合物
JPH06502183A (ja) 新規な４−アリールピペラジン類および４−アリールピペリジン類
JP2006508935A (ja) ヒスタミンｈ１および／もしくはｈ３アンタゴニストまたはｈ３逆アンタゴニストとしての置換ピペラジン、（１，４）ジアゼピン、および２，５−ジアザビシクロ（２．２．１）へプタン。
JPH054984A (ja) カルボスチリル誘導体及びバソプレシン拮抗剤
EA016948B1 (ru) Модуляторы никотиновых ацетилхолиновых рецепторов
JPH08506354A (ja) ５−［２−（４−（ベンゾイソチアゾール−３−イル）−ピペラジン−１−イル）エチル−６−クロロ−１，３−ジヒドロ−インドール−２−オンの製造方法及び製造用中間体
JPH06211839A (ja) 抗ウイルス剤としてのフェノキシ及びフェノキシアルキルピペリジン類
JPH0225913B2 (enExample)
US5432179A (en) Piperazine derivatives and pharmaceuticals containing the same
JPH05140107A (ja) ピリジン化合物
US4791120A (en) 4-heteropentacyclic-4-[N-(phenyl)amino] piperidine derivatives and pharmaceutical compositions and method employing such compounds
JPWO1993002062A1 (ja) ピペラジン誘導体及びこれを含有する医薬
JP3161755B2 (ja) ３−〔１−チアゾリジニルブチル−４−ピペラジニル〕−１ｈ−インダゾール
DE69805033T2 (de) Tetrazolderivate als LTD4 und H1 Antagonisten
JP4472337B2 (ja) アルキルアミノピリダジノン誘導体、この調製方法、およびこれを含む医薬組成物
US6337397B1 (en) Pyrimidine derivatives and their salts, useful for making benzoxazepine derivatives
US4831192A (en) Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
CN101384260A (zh) 哌嗪衍生物
JPH062742B2 (ja) 新規２‐ピラゾリン類及びそれを有効成分とする脳血管障害治療剤

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees